NTAP Form 4: Daniel De Lorenzo Reports RSU Conversions and 172-Share Sale
Rhea-AI Filing Summary
Daniel De Lorenzo, Vice President, Controller & CAO of NetApp, Inc. (NTAP), reported multiple transactions on 08/15/2025. The filing shows an acquisition of 496 common shares and a disposition of 172 common shares sold at $108.79, leaving 779 shares beneficially owned after the non-derivative transactions.
The report also records vesting/conversion of restricted stock units into common shares: four separate RSU conversions totaling 496 shares (69, 107, 146, 174) recorded as vested on 08/15/2025, resulting in 1,025 and 1,925 derivative-share tallies shown after those transactions. Transactions were signed by an attorney-in-fact on 08/19/2025.
Positive
- RSU conversions were reported explicitly, with restricted stock units converting one-for-one into common shares.
- Full disclosure of transaction dates, amounts, and sale price ($108.79) is provided, satisfying Section 16 reporting requirements.
Negative
- Sale of 172 shares on 08/15/2025 reduced direct holdings; the filing does not state the purpose of the sale.
- Beneficial ownership remains relatively small post-transactions (779 shares), indicating limited economic stake reported in this filing.
Insights
TL;DR: Insider recorded RSU vesting and a small open-market sale, netting an increase in exercised shares but overall modest change in beneficial ownership.
The Form 4 documents vested restricted stock units converting one-for-one into common shares on 08/15/2025 and a contemporaneous sale of 172 shares at $108.79. The filing quantifies post-transaction beneficial ownership at 779 common shares and lists derivative holdings tied to prior RSU grants. For investors, this is a routine executive compensation vesting and partial sale rather than a material change in control or large-scale disposition.
TL;DR: The disclosure is a standard Section 16 filing showing RSU vesting and a limited sale by a named officer, properly reported.
The report identifies Daniel De Lorenzo as the reporting person and discloses vesting schedules tied to grants from 2021–2024, with specific tranche conversions recorded on 08/15/2025. The presence of an attorney-in-fact signature and explicit grant/vesting details align with required disclosure practices; there is no indication of unusual timing or undisclosed arrangements in the submitted form.